ESR1 and prostate cancer: Androgen receptor-negative prostate cancer cells PC-3 and DU145, estrogen-receptor positive breast cancer cells MCF7 and triple-negative breast cancer cells MDA MB 231 that exhibit aggressive behaviors were also sensitive to Super-EBS.